|
|||||
|
|
Once‐weekly dulaglutide 1.5 mg restores insulin secretion in response to intravenous glucose infusion |
|
| Authors: | Amparo de la Peña PhD Corina Loghin MD Xuewei Cui PhD Xin Zhang PhD Christoph Kapitza MD Ronan P. Kelly BM BCh DPhil |
| Affiliation: | 1. Eli Lilly and Company, Indianapolis, Indiana;2. Profil, Neuss, Germany;3. Lilly‐NUS Centre for Clinical Pharmacology, Singapore |
| Abstract: | |
| Keywords: | β ‐cells dulaglutide insulin secretion type 2 diabetes |